ARMC
VIR icon

American Research & Management Company’s Vir Biotechnology VIR Stock Holding History

American Research & Management Company’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$4K – 376
2020
Q2 		$4K Hold
100
– – ﹤0.01% 307
2020
Q1 		$3K Buy
+100
New +$2.69K ﹤0.01% 299

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Research & Management Company's VIR Position: Q3 2020 in Review

American Research & Management Company sold out of Vir Biotechnology (VIR) in Q3 2020, closing a stake of 100 shares — an estimated $4K sold.

American Research & Management Company first reported a position in VIR in Q1 2020 and held it in 2 quarters. The position peaked at $4K in Q2 2020. 119 funds tracked by Wall St. Rank hold VIR as of Q3 2020.

  • American Research & Management Company reported no remaining Vir Biotechnology position as of Q3 2020 after selling out during the quarter.
  • American Research & Management Company sold 100 Vir Biotechnology shares in Q3 2020, an estimated $4K.
  • American Research & Management Company first reported a position in Vir Biotechnology in Q1 2020 and held it in 2 quarters.
  • American Research & Management Company's Vir Biotechnology position peaked at $4K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2020.

Based on American Research & Management Company's 13F filing for Q3 2020, filed 29 Oct 2020.